News & Media

All Resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Media Coverage
Media Coverage
November 20, 2024
2024
2024

BillionToOne named the Diagnostics Company of the Year by BioTech Breakthrough Awards

Learn More
Media Coverage
November 20, 2024
2024
2024

BillionToOne named the Diagnostics Company of the Year by BioTech Breakthrough Awards

Learn More
Press Releases
Press Releases
November 12, 2024
2024
2024

Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth

Learn More
Press Releases
November 12, 2024
2024
2024

Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth

Learn More
Media Coverage
Media Coverage
September 27, 2024
2024
2024

The Green Room Podcast from Obstetrics & Gynecology-Interview with Jennifer Hoskovec, MS, author of “Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.”

Learn More
Media Coverage
September 27, 2024
2024
2024

The Green Room Podcast from Obstetrics & Gynecology-Interview with Jennifer Hoskovec, MS, author of “Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.”

Learn More
Media Coverage
Media Coverage
September 17, 2024
2024
2024

A Major Addition to Austin’s Life Science Ecosystem with the Expansion of BillionToOne

Learn More
Media Coverage
September 17, 2024
2024
2024

A Major Addition to Austin’s Life Science Ecosystem with the Expansion of BillionToOne

Learn More
Press Releases
Press Releases
September 4, 2024
2024
2024

Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital

Learn More
Press Releases
September 4, 2024
2024
2024

Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital

Learn More
Press Releases
Press Releases
July 26, 2024
2024
2024

BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping

Learn More
Press Releases
July 26, 2024
2024
2024

BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping

Learn More
Media Coverage
Media Coverage
July 1, 2024
2024
2024

Axios-BillionToOne raises $130M at $1B-plus valuation

Learn More
Media Coverage
July 1, 2024
2024
2024

Axios-BillionToOne raises $130M at $1B-plus valuation

Learn More
Media Coverage
Media Coverage
July 1, 2024
2024
2024

Genomeweb-BillionToOne Raises $130M in Series D Financing Round

Learn More
Media Coverage
July 1, 2024
2024
2024

Genomeweb-BillionToOne Raises $130M in Series D Financing Round

Learn More